Trevi Therapeutics
Price & Volume
Stats
See more52W Range | $4.09-$14.39 |
Market Cap | $1.3B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.37 |
News
See moreYahoo Finance • 3 months ago
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones
Yahoo Finance • 3 months ago
Trevi Therapeutics targets multiple phase III trial launches for chronic cough indications in 2026 as regulatory plans accelerate
Yahoo Finance • 5 months ago
Haduvio Opportunity Positions Trevi (TRVI) for Multibagger Gains, Says Morgan Stanley
Yahoo Finance • 6 months ago
Trevi spikes as B. Riley reportedly cites deal prospects
About
CEO | Ms. Jennifer L. Good |
Address | 195 Church Street, New Haven, CT, United States, 06510 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 34 |
